Juan Andres Moderna, Inc. (MRNA) insider trading activity

Juan Andres is Officer of Moderna, Inc.. Currently has a direct ownership of 12,803 shares of MRNA, which is worth approximately $471,790. The most recent transaction as insider was on Feb 09, 2022, when has been sold 2,000 shares (Common Stock) at a price of $154.26 per share, resulting in proceeds of $308,520. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K

0% 3M change

0% 12M change

Total Value Held $471,790

Juan Andres Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 09 2022	SELL Open market or private sale	$308,520 $154.26 p/Share	2,000 Reduced 100.0%	0 Common Stock
Feb 09 2022	BUY Exercise of conversion of derivative security	$26,591 $7.11 p/Share	3,740 Added 68.25%	1,740 Common Stock
Feb 02 2022	SELL Open market or private sale	$341,780 $170.89 p/Share	2,000 Reduced 100.0%	0 Common Stock
Feb 02 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 50.0%	2,000 Common Stock
Dec 31 2021	SELL Open market or private sale	$1,249,400 $249.88 p/Share	5,000 Reduced 100.0%	0 Common Stock
Dec 31 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Dec 29 2021	SELL Open market or private sale	$1,200,000 $240.0 p/Share	5,000 Reduced 100.0%	0 Common Stock
Dec 29 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Dec 27 2021	SELL Open market or private sale	$2,431,000 $243.1 p/Share	10,000 Reduced 100.0%	0 Common Stock
Dec 27 2021	BUY Exercise of conversion of derivative security	$122,100 $12.21 p/Share	10,000 Added 50.0%	10,000 Common Stock
Dec 22 2021	SELL Open market or private sale	$1,321,300 $264.26 p/Share	5,000 Reduced 100.0%	0 Common Stock
Dec 22 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Dec 20 2021	SELL Open market or private sale	$4,814,550 $320.97 p/Share	15,000 Reduced 100.0%	0 Common Stock
Dec 20 2021	BUY Exercise of conversion of derivative security	$198,300 $13.22 p/Share	15,000 Added 50.0%	15,000 Common Stock
Dec 17 2021	SELL Open market or private sale	$1,378,400 $275.68 p/Share	5,000 Reduced 100.0%	0 Common Stock
Dec 17 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Dec 15 2021	SELL Open market or private sale	$1,360,550 $272.11 p/Share	5,000 Reduced 100.0%	0 Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Dec 13 2021	SELL Open market or private sale	$1,285,050 $257.01 p/Share	5,000 Reduced 100.0%	0 Common Stock
Dec 13 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Dec 10 2021	SELL Open market or private sale	$1,175,000 $235.0 p/Share	5,000 Reduced 100.0%	0 Common Stock
Dec 10 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Dec 08 2021	SELL Open market or private sale	$1,411,750 $282.35 p/Share	5,000 Reduced 100.0%	0 Common Stock
Dec 08 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Dec 06 2021	SELL Open market or private sale	$4,209,000 $280.6 p/Share	15,000 Reduced 100.0%	0 Common Stock

Also insider at

AVTR

Avantor, Inc. Basic Materials

Director

EVLO

Evelo Biosciences, Inc. Healthcare

Director

Juan Andres

Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account